UK-based Mestag Therapeutics has entered a license and collaboration agreement with Merck & Co to explore new therapies for ...

UK-based AviadoBio, a LifeArc Ventures portfolio company, and Astellas Pharma today announced an exclusive option and license ...

Israel-based Teva Pharmaceutical Industries today announced that the US Food and Drug Administration (FDA) has accepted, and ...

China-headquartered clinical-stage biotech MediLink Therapeutics has announced a global clinical trial collaboration and ...

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved Iqirvo (elafibranor), from French drugmaker ...

The US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation for survodutide (BI 456906), which is ...

Japanese drugmaker Eisai has received approval in Thailand for Urece (dotinurad), a treatment for gout and hyperuricemia.

US antivirals specialist Gilead Sciences has released additional data from its pivotal Phase III PURPOSE 2 trial providing an ...

Germany’s Eckert & Ziegler has signed a global clinical supply agreement with Australian firm GlyTherix, providing GMP-grade ...

With its recent US Food and Drug Administration (FDA) approval, Eli Lilly’s Ebglyss (lebrikizumab) adds a new competitor to ...

Cardiopulmonary diseases specialist Liquidia saw an 11% rise in its stock after the US Supreme Court denied United ...

US clinical-stage biotech OnKure Therapeutics has announced the completion of its previously announced merger with Reneo ...